The GATRA is a program whose aim is to identify and support innovative clinical and scientific research aimed at gaining more insight into the current and new uses of Antithrombin.
By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care
Applications for Gatra 2024 will be accepted between 01/11/2023 and 30/04/2024.
Please click here to apply.
To see the 2023 GATRA Award winner please click here.